Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | $78.3M | $78.3M | $93.7M | $94.0M | $116.2M | $122.2M | $141.3M | $161.8M | $178.3M | $187.8M | $181.9M | $192.1M | $222.0M | $263.1M | $377.0M | $427.7M | $581.8M | $744.8M | $679.1M | $845.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, IDEXX Laboratories, Inc.'s last 12-month Net Income is $887.9M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, IDEXX Laboratories, Inc.'s Net Income growth was 5.1%. The average annual Net Income growth rates for IDEXX Laboratories, Inc. have been 6.8% over the past three years, 15.7% over the past five years.
Over the last year, IDEXX Laboratories, Inc.'s Net Income growth was 5.1%, which is higher than industry growth of (0.2%). It indicates that IDEXX Laboratories, Inc.'s Net Income growth is Good.